Operators First. Fund Managers Second.
Veracor Capital wasn't built by Wall Street. It was built by the people who spent 20 years in clinics, manufacturing floors, and operating rooms — then created a fund to scale what they'd already proven.
The Operator Behind the Fund
Kenton Gray
U.S. Army veteran. Former aspiring NASCAR driver. 20+ years building healthcare companies from zero.
Kenton didn't come from finance — he came from the clinic. He developed Signal-Based Medicine through years of direct patient care, treating chronic disease at its root cause. That methodology has been validated across 47,000+ patients with a 95% clinical success rate.
He built KureCare (wound care, $4.6M 2025 revenue), EliteMD (national medical director network), Pure Pak (150,000 sq ft FDA-registered manufacturing), and the broader Kure Health ecosystem — all before forming a fund. Veracor Capital exists because these companies needed growth capital, not because someone needed a fund to manage.
His experience spans clinical operations, consumer product development (RIIZE STRIPS — $3.6M year one), manufacturing, and healthcare technology (KureOS AI platform). The fund was created to back innovations he already built.
Veteran-Owned & OperatedWhat the Founder Built Before the Fund
KureCare — Wound Care Division
Operating under Max Health LA, KureCare treats chronic wounds with 95% healing rates. Generated $4.6M in 2025 revenue with proven Medicare-reimbursable protocols.
EliteMD — Medical Director Network
National network of medical directors providing clinical oversight to healthcare organizations. Recurring revenue model with SaaS-like characteristics across 50 states.
Pure Pak Inc. — Manufacturing
FDA-registered 150,000 sq ft nutraceutical contract manufacturer. Provides vertical integration for the entire supplement supply chain from formulation to fulfillment.
RIIZE STRIPS — Consumer Health
$3.6M in first-year revenue (2024) as prescription-only. Strategically pivoted to DTC-only model in 2025 build year. Nationwide DTC launch planned for 2026.
KureOS — AI Clinical Platform
AI-powered clinical decision support platform in active development. Designed to codify Signal-Based Medicine protocols for scalable deployment across clinical networks.
Signal-Based Medicine™
Proprietary methodology developed over 20 years. Treats root causes of chronic disease rather than managing symptoms. 47,000+ patients, 95% success rate — the IP moat behind every portfolio company.
Building the Right Team at the Right Time
Veracor Capital is an emerging fund — and we're transparent about that. We're not padding the page with placeholder executives. As the fund grows, we're methodically building the team with experienced professionals in fund operations, investor relations, legal, and clinical oversight.
Key hires in finance, compliance, and operations will be announced as they are formally onboarded. Our advisory board is being assembled with healthcare executives and institutional investors who bring complementary expertise.
Strategic Advisors
Our advisory board includes experienced healthcare executives, institutional investors, and regulatory specialists who provide strategic guidance on fund operations, clinical expansion, and market positioning.
Advisory board members will be announced as they are formally onboarded. If you have relevant expertise and interest in healthcare transformation, we welcome the conversation.